Clinical trial
Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in…
NCT00432016 · RFS Pharma, LLC, Industry · Completed
Key facts
| NCT number | NCT00432016 |
|---|---|
| Title | Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV |
| Official title | A Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerance, Pharmacokinetics and Antiviral Activity of Amdoxovir and Zidovudine in Untreated HIV-1 Infected Subjects Currently Untreated |
| Lead sponsor | RFS Pharma, LLC, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug, Procedure |
| Interventions | zidovudine, amdoxovir, pharmacokinetic sampling |
| Enrollment | 24 |
| Start date | Feb 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Feb 6, 2007 |
| Last update posted | May 11, 2007 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: